Related Experiment Video
Updated: Oct 8, 2025

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Regulatory effects of miR-28 on osteogenic differentiation of human bone marrow mesenchymal stem cells
Min Wang1, Tianming Dai1, Qingqi Meng1
1Department of Orthopedics, Guangzhou Red Cross Hospital, Jinan University, Guangzhou Guangdong Province, China.
Abstract:
We aimed to assess the regulatory effects of miR-28 on the osteogenic differentiation of human bone marrow mesenchymal stem cells (hBMMSCs). HBMMSCs isolated, cultured and induced (at P3) to undergo osteogenic induction. The expressions of miRNAs were detected by gene microarray, and differentially expressed miRNAs in hBMMSCs compared with induced cells were obtained by significance analysis of microarrays. The microarray findings were confirmed by RT-PCR. TargetScan showed that signal transducer and activator of transcription 1 (STAT1) was the downstream target gene of miR-28. The relationship between miR-28 and STAT1 was validated using dual-luciferase reporter gene assay. HBMMSCs were transfected with miR-28 mimics and STAT1 siRNA, respectively. Samples were collected on day 10 after osteogenic differentiation, and the alkaline phosphatase (AKP) activity, Runt-related transcription factor 2 (RUNX2, a key regulator of osteogenic differentiation) and STAT1 expressions were determined using kits, PCR and Western blotting, respectively. Cell proliferation and migration were detected through CCK-8 and Transwell assays, respectively. During the osteogenic differentiation of hBMMSCs, the expression level of miR-28 increased. MiR-28 specifically bound the 3'-untranslated region (3'UTR) of STAT1 mRNA. It inhibited STAT1 expression in a targeted manner during osteogenic differentiation. Interference with STAT1 partially mimicked the regulatory effects of miR-28 overexpression on the osteogenic differentiation of hBMMSCs. Interference with STAT1 or overexpression of miR-28 did not affect proliferation or migration. MiR-28 has gradually increased expression during the osteogenic differentiation of hBMMSCs, which can directly bind STAT1 3'UTR and inhibit its expression, thereby up-regulating AKP and RUNX2, and promoting osteogenic differentiation.
Insights
MicroRNA-28 (miR-28) promotes bone formation by targeting STAT1 in human mesenchymal stem cells. Increased miR-28 expression enhances osteogenic differentiation, crucial for bone development and repair.
Area of Science:
- Molecular Biology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Mesenchymal stem cells (MSCs) are critical for bone regeneration.
- MicroRNAs (miRNAs) play regulatory roles in stem cell differentiation.
- The specific role of miR-28 in osteogenic differentiation of human bone marrow mesenchymal stem cells (hBMMSCs) requires elucidation.
Purpose of the Study:
- To investigate the regulatory function of miR-28 in the osteogenic differentiation of hBMMSCs.
- To identify the downstream target of miR-28 involved in this process.
Main Methods:
- hBMMSCs were isolated, cultured, and induced for osteogenic differentiation.
- miRNA expression profiling was performed using gene microarrays and validated by RT-PCR.
- TargetScan, dual-luciferase reporter assays, transfection with miR-28 mimics/STAT1 siRNA, Western blotting, and RT-PCR were used to confirm interactions and effects.
Main Results:
- miR-28 expression significantly increased during hBMMSC osteogenic differentiation.
- miR-28 directly targets the 3'-untranslated region (3'UTR) of signal transducer and activator of transcription 1 (STAT1) mRNA, inhibiting its expression.
- Overexpression of miR-28 or inhibition of STAT1 promoted alkaline phosphatase (AKP) activity and Runt-related transcription factor 2 (RUNX2) expression, key markers of osteogenesis.
Conclusions:
- miR-28 acts as a positive regulator of hBMMSC osteogenic differentiation.
- The mechanism involves direct inhibition of STAT1 expression.
- miR-28 holds potential as a therapeutic target for enhancing bone formation.
Related Concept Videos
Mesenchymal Stem Cells
Master Transcription Regulators

